DOI:
10.1039/C4RA03232B
(Paper)
RSC Adv., 2014,
4, 26301-26308
Manganese(II) chloride catalyzed highly efficient one-pot synthesis of propargylamines and fused triazoles via three-component coupling reaction under solvent-free condition†
Received
10th April 2014
, Accepted 23rd May 2014
First published on 23rd May 2014
Abstract
A one-pot green and highly efficient method for the synthesis of propargylamines and diastereoselective synthesis of fused triazoles via three-component coupling in the presence of manganese(II) chloride as a catalyst and a catalyst-free 1,3-dipolar cycloaddition reaction, respectively, without using a co-catalyst or activator is reported. This methodology is efficient, eco-friendly, operationally simple and effective for reactions involving aromatic, aliphatic, and heterocyclic aldehydes, and provides an easy access to propargylamines in excellent yields, fused triazoles in good yield and excellent diastereoselectivities.
Introduction
Development of environmentally benign methods by avoiding toxic reagents and solvents has become increasingly important for industrial applications.1 Multicomponent coupling reaction2,3 (MCR) is of potential interest as it enables the coupling of aldehydes, amines, and alkynes, resulting in propargylamines with new C–C bonds.2,3 A solvent-free reaction4 is an important synthetic boon from the viewpoint of green and sustainable chemistry. Over the past few years, solvent-free heterocyclic synthesis5 has rapidly increased, which has paved the way for the development of greener synthesis.6 The synthesis of propargylamine is an intense research area in organic synthesis because propargylamine is a versatile building block in natural product synthesis,7 which acts as a precursor in the synthesis of nitrogen-containing heterocyclic compounds.8a–f,9 Moreover, propargylamines are frequent skeletons10a and synthetically versatile key intermediates11 for the synthesis of biologically active compounds such as β-lactams, oxotremorine analogues, conformationally restricted peptides, isosteres and therapeutic drug molecules.10b,12 Traditionally, propargylamines are synthesized by the nucleophilic attack of lithium acetylides or Grignard reagents to imines or their derivatives.13 However, these reagents are stoichiometric, highly moisture sensitive and require strictly controlled reaction conditions.
To overcome such problems, tremendous progress has been made in recent years to develop an alternative atom-economical approach to their synthesis for performing this type of reaction by the catalytic coupling of three components (A3 coupling) by C–H activation, where water is the only theoretical by-product.3 Various transition metal catalysts for the C–H bond activation of terminal alkynes, such as CuI salts,14 CuII derivatives,15a Cu/RuII bimetallic systems,15b IrI complexes,16 AuI/AuIII salts,17 AuIII salen complexes,18 AgI salts,19 InIII salts,20 NiII salts,21 and FeIII salts,22 have been used for this reaction under homogeneous reaction conditions. Recently, Ag(I)23a and Cu(I)23b in ionic liquids, Zn dust,24 supported Au(III),25a Ag(I),25b–d or Cu(I),26 Fe3O4 nanoparticles,27 and nano indium oxide26 were successfully used to catalyze A3 coupling reactions under heterogeneous reaction conditions with the recyclability and reusability of the transition metal catalyst.25g,28
Huisgen 1,3-dipolar cycloaddition, the reaction of a dipolarophile (alkyne) with a 1,3-dipolar (azide) compound that leads to 1,2,3-triazole (five-membered ring), has attracted significant attention as one of the most important heterocycles.29 Within the past few years, applications of this building block have been widely extended into various research fields30 such as chemical biology, materials science, and medicinal chemistry. 1,2,3-Triazole moiety is present in several compounds exhibiting different biological properties such as antibacterial31 (cefmatilen), anti-HIV,32 antiallergic,33 and inhibitory (tazobactam) activities. Triazolobenzodiazepines34 have shown high affinity toward benzodiazepine receptors. Triazole chemistry was revisited and has seen exponential growth over the years and enormous gain in popularity in areas of chemistry such as dyes, photostabilizers, agrochemicals35 and in the designining of new drugs.36 Among the nitrogen heterocycles, tetrahydropyrazine represents an important class of organic molecules that attracts interest of both synthetic and medicinal chemists due to its significant biological activities.37
Recently, we described a practical and efficient two-step protocol for the synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines38 (Scheme 1). The first step involved AuBr3 catalyzed three-component coupling of aldehyde, amine and alkyne to form propargylamines, and in second step, propargylamine underwent intramolecular 1,3-dipolar cycloaddition using DMF as a solvent. In this paper, briefly considering the importance of propargylamine, 1,2,3-triazole moiety, tetrahydropyrazine and eco-friendly reaction conditions, we present for the first time the use Mn(II) chloride as an efficient catalyst for the synthesis of propargylamine via three-component coupling and one-pot diastereoselective synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines via three-component coupling followed by Huisgen intramolecular 1,3-dipolar cycloaddition reaction at solvent-free conditions. To the best of our knowledge, the utilization of manganese chloride for three-component coupling of aldehyde, amine and alkyne has never been reported. Manganese chloride has received a significant amount of interest because it is inexpensive, easily available, easy to handle and relatively insensitive to air and moisture. Moreover, it has been used for cross-coupling reactions between aryl Grignard reagents and simple alkenyl halides.39
 |
| Scheme 1 Diastereoselective synthesis of propargylamines and 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines. | |
Results and discussion
Manganese(II) chloride catalyzed three-component coupling reaction
We focused our initial investigation on the effects of various types of solvents and catalyst loading on the reaction of benzaldehyde, piperidine and phenylacetylene at different temperatures (Table 1). The results indicate that reaction temperature, solvent and catalyst loading influence the product yield in the A3 coupling reaction. After several screening experiments, the best condition was proven to be a mixture of benzaldehyde (1 mmol), piperidine (1.2 mmol), phenyl acetylene (1.5 mmol) and MnCl2 (10 mol%), which was stirred at 90 °C without solvent for 12 h (Table 1, entry 9). We first started to screen solvents with water but there was no formation of the desired product (Table 1, entry 1). Then, we screened various organic solvents on the A3 coupling of model substrates by using 10 mol% of MnCl2 as catalysts such as DMF, DMSO, dioxane, and DCM, at 100 °C, 80 °C, 101 °C, and 35 °C, respectively, which generated the corresponding products in very small amounts (Table 1, entries 2, 3, 5 and 7). Using ethanol and acetonitrile as solvents afforded the desired products in 45% and 61% yields, respectively, at 80 °C (Table 1, entries 4 and 6), whereas toluene was inferior and generated the corresponding product in moderate yield (88%) at 120 °C (Table 1, entry 8). To further investigate the reaction conditions, the same reaction with 10 mol% of MnCl2 was carried out at solvent-free conditions at 90 °C, which afforded the desired product in a 98% yield (Table 1, entry 9). To produce the most effective catalyst for the coupling of aldehyde, amine and alkyne, we used 10 mol% of Mn powder, MnO2, and Mn(OAc)2·4H2O to catalyze the reaction at solvent-free conditions at 90 °C with conversions of 51%, 20%, and 62%, respectively (Table 1, entries 10–12). Next, we performed the reaction with 2 mol% MnCl2 and 5 mol% MnCl2, which generated the desired product in 69% and 82% yields, respectively (Table 1, entries 13 and 14), and we observed that higher catalyst loading increased the yield of the desired product and decreased the reaction time. Therefore, using MnCl2 (10 mol%) at 90 °C in solvent-free conditions (Table 1, entry 9) was selected to be the best combination for the A3 coupling reaction of aldehyde, amine and alkyne.
Table 1 Optimization studies for the MnCl2 catalyzed multicomponent synthesis of propargylamine 4aa

|
Entry |
Mn source (mol%) |
Solvent |
Temp (°C) |
Time (h) |
4a (%) |
Reaction conditions: 1a – aldehyde (1 mmol), 2a – amine (1.2 mmol), 3a – alkyne (1.5 mmol) with 10 mol% manganese source heated with solvents and without solvent at different temperatures. |
1 |
MnCl2 (10) |
H2O |
100 |
24 |
0 |
2 |
MnCl2 (10) |
DMF |
100 |
24 |
Traces |
3 |
MnCl2 (10) |
DMSO |
80 |
24 |
Traces |
4 |
MnCl2 (10) |
Ethanol |
80 |
24 |
45 |
5 |
MnCl2 (10) |
Dioxane |
101 |
24 |
Traces |
6 |
MnCl2 (10) |
CH3CN |
80 |
24 |
61 |
7 |
MnCl2 (10) |
CH2Cl2 |
35 |
72 |
Traces |
8 |
MnCl2 (10) |
Toluene |
120 |
14 |
88 |
9 |
MnCl2 (10) |
— |
90 |
12 |
98 |
10 |
Mn (10) |
— |
90 |
18 |
51 |
11 |
MnO2 (10) |
— |
90 |
12 |
20 |
12 |
Mn(OAc)2·4H2O (10) |
— |
90 |
16 |
62 |
13 |
MnCl2 (2) |
— |
90 |
15 |
69 |
14 |
MnCl2 (5) |
— |
90 |
14 |
82 |
The catalysis was applied to various aldehydes, alkynes and amines at optimized conditions, as summarized in Table 2. Initially, we performed the coupling of benzaldehyde and phenylacetylene with cyclic amines such as piperidine and morpholine, leading to products 1a and 1b with yields of 98% and 90%, respectively (Table 1, entries 1 and 2). Considering the high reactivity of benzaldehyde with morpholine and phenylacetylene in the A3 coupling reaction, we also studied the reactivity of aliphatic and heterocyclic aldehydes, such as isobutyraldehyde and 3-thienyl carbaldehyde, with morpholine and phenylacetylene under optimized reaction conditions. Surprisingly, both the desired products 1c and 1d were generated with excellent yields of 96% and 93%, respectively (Table 1, entries 3 and 4). In the case of diisopropylamine and aniline, the desired products 1e and 1f were generated with 65% and 69% yields, respectively (Table 2, entries 5 and 6). We also tried various aliphatic primary amines in the A3 coupling reaction but there was no formation of the desired product. Benzaldehyde-bearing electron-donating and electron-withdrawing groups at o-, m-, and p-positions, such as alkyl, chloro, and fluoro, were able to undergo three-component coupling and generated the corresponding products, 1g–1m, in excellent yields (91–97%) (Table 2, entries 7–13). The electronic properties of the substituents on the phenyl ring did not have an obvious effect on the yields of corresponding products. 1-Napthaldehyde and biphenyl-2-carbaldehyde reacted well under optimized conditions, even though they are bulky, and furnished desired products 1n and 1o with 96% and 94% yields, respectively (Table 2, entries 14 and 15). Aliphatic alkynes, such as trimethylsilyl acetelyne, worked effectively and furnished the product 1p in a good yield of 89% (Table 2, entry 16). The aromatic alkyne-bearing electron-donating group (methoxy) showed good reactivity in the A3 coupling reaction under optimized conditions and generated the desired product 1q in a very high yield of 97% (Table 2, entry 17). Because of the excellent yield in the case of benzaldehyde, we also studied the reactivity of p-methoxyphenyl acetylene with the substituted benzaldehyde-bearing electron-donating and electron-withdrawing groups in the A3 coupling reaction such as p-tolualdehyde, m-chlorobenzaldehyde and with aliphatic aldehyde such as trimethylacetaldehyde. The desired products 1r, 1s and 1t were generated in excellent yields of 96%, 94% and 98%, respectively (Table 2, entries 18–20). Aliphatic aldehydes displayed high reactivity under the optimized reaction conditions and generated the desired products 1u–1ad in excellent yields (95–98%) (Table 2, entries 21–30). Trimerization in the case of aliphatic aldehydes was never observed, even though it has been a major limitation of the A3 coupling reaction.14,17 Heterocyclic aldehydes, such as 2-thienyl carbaldehyde and 3-thienyl carbaldehyde, reacted smoothly under optimized reaction condition to give 1ae and 1af in 91% and 97% yields, respectively (Table 2, entries 31 and 32). The structure of 1a in the CDCl3 methine proton (N–CH–) at δ = 4.79 ppm was observed as a characteristic singlet, and in the 13C NMR spectrum, two peaks at δ = 85.97 ppm and 87.80 ppm corresponding to the two acetylenic carbons were observed. These observations supported the formation of propargylamine (1a).
Table 2 MnCl2 catalyzed one-pot synthesis of propargylamines 1a–1afa

|
Entry |
Aldehyde (R1) |
Amine (R2, R3) |
Alkyne (R4) |
Product |
Yieldb (%) |
Reaction conditions: aldehyde (1.0 mmol), amine (1.2 mmol), and phenylacetylene (1.5 mmol), MnCl2 (10 mol %) heated at solvent-free condition at 90 °C in a sealed tube. Isolated yields after flash chromatography. |
1 |
ph |
Piperidine |
ph |
1a |
98 |
2 |
ph |
Morpholine |
ph |
1b |
90 |
3 |
Isopropyl |
Morpholine |
ph |
1c |
96 |
4 |
3-Thienyl |
Morpholine |
ph |
1d |
93 |
5 |
ph |
Diisopropyl amine |
ph |
1e |
65 |
6 |
ph |
Aniline |
ph |
1f |
69 |
7 |
o-CH3C6H4 |
Piperidine |
ph |
1g |
91 |
8 |
m-CH3C6H4 |
Piperidine |
ph |
1h |
95 |
9 |
p-CH3C6H4 |
Piperidine |
ph |
1i |
97 |
10 |
o-ClC6H4 |
Piperidine |
ph |
1j |
93 |
11 |
m-ClC6H4 |
Piperidine |
ph |
1k |
92 |
12 |
p-ClC6H4 |
Piperidine |
ph |
1l |
96 |
13 |
p-FC6H4 |
Piperidine |
ph |
1m |
94 |
14 |
1-napthyl |
Piperidine |
ph |
1n |
96 |
15 |
2-(1,1′-biphenyl) |
Piperidine |
ph |
1o |
94 |
16 |
ph |
Piperidine |
(CH3)3Si |
1p |
89 |
17 |
ph |
Piperidine |
p-CH3OC6H4 |
1q |
97 |
18 |
p-CH3C6H4 |
Piperidine |
p-CH3OC6H4 |
1r |
96 |
19 |
m-ClC6H4 |
Piperidine |
p-CH3OC6H4 |
1s |
94 |
20 |
Tert-butyl |
Piperidine |
p-CH3OC6H4 |
1t |
98 |
21 |
Cyclohexyl |
Piperidine |
ph |
1u |
95 |
22 |
Tert-butyl |
Piperidine |
ph |
1v |
97 |
23 |
Ethyl |
Piperidine |
ph |
1w |
96 |
24 |
Propyl |
Piperidine |
ph |
1x |
95 |
25 |
Pentyl |
Piperidine |
ph |
1y |
97 |
26 |
Hexyl |
Piperidine |
ph |
1z |
96 |
27 |
Heptyl |
Piperidine |
ph |
1aa |
97 |
28 |
Octyl |
Piperidine |
ph |
1ab |
98 |
29 |
Nonyl |
Piperidine |
ph |
1ac |
96 |
30 |
Ph–(CH2)2– |
Piperidine |
ph |
1ad |
97 |
31 |
2-Thienyl |
Piperidine |
ph |
1ae |
91 |
32 |
3-Thienyl |
Piperidine |
ph |
1af |
97 |
Manganese(II) chloride catalyzed three-component coupling followed by catalyst free 1,3-dipolar cycloaddition
With the development of this simple and effective method, our next step was to develop a one-pot synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines via three-component coupling of aldehyde, amine and alkyne followed by 1,3-dipolar cycloaddition. During our investigation, it was observed that MnCl2 could provide 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines in good yield and excellent diastereoselectivity without a solvent in one-pot operation. Encouraged by this result, we started our methodology by preparing (S)-azidomethylpyrrolidine from commercially available L-proline by following a reported procedure.40
After establishing the optimal reaction condition for the synthesis of propargylamine via the three-component coupling of benzaldehyde, piperidine and phenyl acetylene, we tested the scope of benzaldehyde, (S)-azidomethylpyrrolidine and phenyl acetylene at above optimized condition and fortunately found that both the reactions, i.e. coupling and intramolecular Huisgen [3 + 2] dipolar cycloaddition, were proceeding well in one pot-operation and furnished the desired product 2a with an 84% yield and excellent diastereoselectivity (Table 3, entry 1). Next, we tested DMF, with toluene as a solvent, for the synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d] via three-component coupling followed by 1,3-dipolar cycloaddition. These solvents also generated the desired product in good yields, but considering the toxicity of these solvents, we decided to carry out further reactions with different substrates at solvent-free conditions. This method is applicable for aromatic, aliphatic, and heterocyclic aldehydes and for aliphatic and aromatic alkynes. It avoids the isolation, purification and characterization of the coupling product (1). Aromatic aldehydes formed the desired products 2b–2l in good yields (75–83%) and excellent diastereoselectivities via three-component coupling followed by 1,3-dipolar cycloaddition reaction (Table 3, entries 2–12). 1-Napthaldehyde also reacted well under the optimized condition and furnished the desired product 2m in an 81% yield and excellent diastereoselectivity. In addition, alkynes such as p-methoxyphenyl acetylene and 1-hexyne reacted well under the optimized reaction condition and generated the desired products 2n and 2o in 83% and 74% yields, respectively, and excellent diastereoselectivities (Table 3, entries 14 and 15). Aliphatic aldehydes such as 3-phenylpropanal, isovaleraldehyde and butanal displayed good reactivity under the optimized reaction condition. This time, we also screened various types of heterocyclic aldehydes but only 3-thienyl carbaldehyde and 2-thienyl carbaldehyde showed good reactivity under the optimized reaction condition and generated desired products 2s and 2t in 82% and 78% yields, respectively, and excellent diastereoselectivities (Table 3, entries 19 and 20). The structure of the fused tricyclic compound 2a was confirmed by 1H NMR 13C NMR, IR and mass spectrometry. In 1H NMR, the spectrum of the compound 2a in the CDCl3 methine proton (N–CH–) at δ = 5.52 ppm was observed as a characteristic singlet, and in the 13C NMR spectrum, two peaks at δ = 128.9 ppm and 141.6 ppm corresponded to olefinic carbon atoms of the triazole ring. These observations confirm the formation of the desired product 2a. The absolute configuration of (4S,8aS)-3-phenyl-4-(thien-3-yl)-4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines was confirmed by the X-ray diffraction analysis of the monocrystals, which clarified that the newly formed stereocenter exhibited an (S) configuration. The configurations of the other products were assigned (S) by analogy (Fig. 1).
Table 3 One-pot diastereoselective synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines 2a–2t at solvent-free conditiona

|
Entry |
R1 |
R2 |
Product |
Yieldc (%) |
Time (h) |
Reaction condition: aldehyde (1.0 mmol.), (S)-azidomethylpyrrolidine (1.2 mmol), phenylacetylene (1.5 mmol.), MnCl2 (10 mol %), heated at solvent-free condition at 90 °C in sealed tube. Diastereomeric ratio was determined by 1H NMR spectroscopy. Isolated yields after flash chromatography. |
1 |
Ph |
Ph |
2a |
84 |
12 |
2 |
4-MeC6H4 |
Ph |
2b |
83 |
12 |
3 |
3-MeC6H4 |
Ph |
2c |
81 |
12 |
4 |
2-MeC6H4 |
Ph |
2d |
79 |
12 |
5 |
4-MeOC6H4 |
ph |
2e |
76 |
12 |
6 |
3-BrC6H4 |
Ph |
2f |
77 |
12 |
7 |
4-FC6H4 |
Ph |
2g |
79 |
12 |
8 |
3-FC6H4 |
Ph |
2h |
77 |
12 |
9 |
3-CNC6H4 |
Ph |
2i |
75 |
12.5 |
10 |
4-ClC6H4 |
Ph |
2j |
82 |
12 |
11 |
3-ClC6H4 |
Ph |
2k |
79 |
12 |
12 |
2-ClC6H4 |
Ph |
2l |
76 |
12 |
13 |
1-Napthyl |
ph |
2m |
81 |
13 |
14 |
ph |
p-CH3OC6H4 |
2n |
83 |
13.5 |
15 |
Ph |
1-Hexyne |
2o |
74 |
12.5 |
16 |
Ph(CH2)2 |
ph |
2p |
77 |
12 |
17 |
Isobutyl |
ph |
2q |
76 |
12 |
18 |
Propyl |
ph |
2r |
75 |
12 |
19 |
3-Thienyl |
ph |
2s |
82 |
14 |
20 |
2-Thienyl |
ph |
2t |
78 |
14 |
 |
| Fig. 1 Crystal structure of (4S,8aS)-3-phenyl-4-(thien-3-yl)-4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazine (2s). | |
The possible mechanism involved manganese(II) chloride reaction with alkyne and manganese acetylide intermediate, which generated hydrochloric acid. We predicted the formation of HCl, which accelerated the formation of the immonium ion generated in situ from aldehydes and secondary amine.41a,41b As a result, manganese acetylide subsequently reacted with the immonium salt formed in situ to form propargylamine and regenerated the Mn(II) catalyst for further reactions.
One-pot synthesis of fused triazoles includes the in situ formation of propargylamine (1) using Mn(II) chloride as a mechanistic pathway for the formation of (1). This process is the same as shown in Scheme 2. Further, propargylamines undergo catalyst-free intramolecular 1,3-dipolar cycloaddition on heating.38,42
 |
| Scheme 2 Possible mechanism for the manganese(II) chloride catalyzed three-component coupling reaction of aldehyde, amine and alkyne. | |
Conclusion
We have successfully developed a novel, efficient, operationally simple, economical and enviornmental friendly MnCl2 catalyzed one-pot synthesis of propargylamines via three-component coupling. Meanwhile, the one-pot diastereoselective synthesis of 4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines was conducted via three-component coupling followed by catalyst-free 1,3-dipolar cycloaddition reaction at solvent free-conditions. The process requires manganese chloride as an inexpensive catalyst and generates a diverse range of propargylamine and interesting fused heterocycle, 4,6,7,8,8a,9 hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazines. Manganese catalysis is an interesting field of investigation for sustainable development. Synthetic application of the A3 coupling reaction and 1,3-dipolar cycloaddition are currently under investigation.
Experimental section
General experimental procedure for manganese(II) chloride catalyzed three-component coupling reaction
A mixture of aldehyde (1.0 mmol), amine (1.2 mmol), alkyne (1.5 mmol) and MnCl2 (10 mol%) was stirred without a solvent for 12 h at 90 °C in a sealed tube. The progress of the reaction was monitored by TLC. After the completion of the reaction, the product was purified by column chromatography using n-hexane–EtOAc as an eluent to give the desired product. The products were identified by FT-IR, 1H and 13C NMR spectroscopy, LRMS and HRMS.
1-(1,3-Diphenylprop-2-yn-1-yl)piperidine 1a. Rf = 0.44 (EtOAc–hexane 1
:
9), yield: 98%, pale yellow solid; mp: 66–67 °C. 1H NMR (300 MHz, CDCl3, ppm δ): 7.64–7.62 (d, J = 6.0 Hz, 2H), 7.53–7.50 (m, 2H), 7.38–7.28 (m, 6H), 4.79 (s, 1H), 2.57–2.54 (m, 4H), 1.61–1.56 (m, 4H), 1.47–1.42 (m, 2H); 13C NMR (75 MHz, CDCl3, δ): 138.52, 131.69, 128.38, 128.15, 127.93, 127.34, 123.27, 87.80, 85.97, 62.29, 50.61, 26.10, 24.36; IR (KBr, thin film, cm−1): 3049, 2923, 2802 1596, 1486, 1445, 1270, 1152, 1094, 758, 691; LRMS-EI (m/z): 275 (12), 246 (3), 232 (4), 198 (50), 191 (100), 165 (7), 139 (2), 115 (9), 86 (5), 56 (6); HRMS-EI (m/z): M+ calcd for C20H21N, 275.1674; found: 275.1669.
General experimental procedure for manganese(II) chloride catalyzed three-component coupling followed by catalyst-free 1,3-dipolar cycloaddition reaction
A mixture of aldehyde (1.0 mmol), (S)-azidomethylpyrrolidine (1.2 mmol), alkyne (1.5 mmol) and MnCl2 (10 mol%) was stirred without a solvent for 12–14 h at 90 °C in a sealed tube. The progress of the reaction was monitored by TLC. After the completion of the reaction, the product was purified by column chromatography using n-hexane–EtOAc as an eluent to give the desired product. The products were identified by FT-IR,1H and 13C NMR spectroscopy, LRMS and HRMS.
4S,8aS-3,4-diphenyl-4,6,7,8,8a,9-hexahydropyrrolo[1,2-a][1,2,3]triazolo[1,5-d]pyrazine 2a. Rf = 0.31 (EtOAc–hexane 3
:
7), yield: 84%. Diastereomeric ratio: >99, [α]25D −79.2° (c 1.0, CHCl3), brown solid, mp: 198–199 °C. 1H NMR (300 MHz, CDCl3, ppm, δ): 7.49–7.47 (d, J = 6.0 Hz, 2H), 7.32–7.30 (d, J = 6.0 Hz, 3H), 7.–7.17 (m, 3H), 7.10–7.01 (m, 2H), 5.56 (s, 1H), 4.83–4.77 (m, 1H), 4.12–4.04 (t, J = 12.0 Hz, 1H), 3.–3.22 (m, 1H), 2.96–2.92 (m, 1H), 2.38–2.25 (q, J = 9.0 Hz, 1H), 1.99–1.90 (m, 2H), 1.76–1.72 (m, 1H), 1.60–1.50 (m, 1H); 13C NMR (100 MHz, CDCl3, ppm, δ): 141.92, 134.71, 130.83, 130.74, 129.23, 128.87, 128.33, 128.16, 127.99, 127.92, 127.41, 127.33, 126.20, 58.02, 51.67, 49.97, 48.63, 27.69, 21.92; IR (KBr, thin film, cm−1): 3056, 3027, 2950, 2876, 2808, 1493, 1448, 1127, 1007, 722, 696; LRMS-EI (m/z): 317 (80), 287 (20), 277 (23), 191 (22), 138 (69), 106 (100), 65 (39); HRMS-EI (m/z) M+ calcd for C20H20N4, 316.1688; found 316.1681.
Acknowledgements
The authors thank Ms L. M. Hsu, at the Instruments Center, National Chung Hsing University, for her help in obtaining mass spectral data, and the National Science Council of the Republic of China, for financially supporting this research under the contract NSC 100-2113-M-259-006-MY3.
Notes and references
- For recent reviews, see:
(a) R. A. Sheldon, Green Chem., 2005, 7, 267–278 RSC;
(b) R. Noyori, Chem. Commun., 2005, 1807–1811 RSC;
(c) M. J. Eckelman, J. B. Zimmerman and P. T. Anastas, J. Ind. Ecol., 2008, 12, 316–328 CrossRef CAS PubMed;
(d) R. A. Sheldon, Chem. Commun., 2008, 3352–3365 RSC.
- C. J. Li, Acc. Chem. Res., 2010, 43, 581–590 CrossRef CAS PubMed.
- V. A. Peshkov, O. P. Pereshivko and E. V. Van der Eycken, Chem. Soc. Rev., 2012, 41, 3790–3807 RSC.
-
(a) N. R. Candeias, L. C. Branco, P. M. P. Gois, C. A. M. Afonso and A. F. Trindade, Chem. Rev., 2009, 109, 2703–2802 CrossRef CAS PubMed;
(b) J. Gálvez, M. Gálvez-Llompart and R. García-Domenech, Green Chem., 2010, 12, 1056–1061 RSC;
(c) J.-N. Tan, M.-H. Li and Y.-L. Gu, Green Chem., 2010, 12, 908–914 RSC;
(d) Y.-N. Zhao, J. Li, C.-J. Li, K. Yin, D.-Y. Ye and X.-S. Jia, Green Chem., 2010, 12, 1370–1372 RSC;
(e) D. B. Ramachary and S. Jain, Org. Biomol. Chem., 2011, 9, 1277–1300 RSC;
(f) B. Jiang, X. Wang, F. Shi, S.-J. Tu and G.-G. Li, Org. Biomol. Chem., 2011, 9, 4025–4028 RSC.
-
(a) M. A. P. Martins, C. P. Frizzo, D. N. Moreira, L. Buriol and P. Machado, Chem. Rev., 2009, 109, 4140–4182 CrossRef CAS PubMed;
(b) G.-W. Wang and C.-B. Miao, Green Chem., 2006, 8, 1080–1085 RSC;
(c) S.-J. Yan, Y.-L. Chen, L. Liu, N.-Q. He and J. Lin, Green Chem., 2010, 12, 2043–2052 RSC.
-
(a) B. Ganem, Acc. Chem. Res., 2009, 42, 463–472 CrossRef CAS PubMed;
(b) B. T. Barry and G. H. Dennis, Chem. Rev., 2009, 109, 4439–4486 CrossRef PubMed;
(c) K. Kumaravel and G. Vasuki, Green Chem., 2009, 11, 1945–1947 RSC;
(d) B. Jiang, S.-J. Tu, P. Kaur, W. Wever and G.-G. Li, J. Am. Chem. Soc., 2009, 131, 11660–11661 CrossRef CAS PubMed;
(e) K. Aditya and T. Béla, Green Chem., 2010, 12, 875–878 RSC;
(f) N. R. Candeias, L. F. Veiros, C. A. M. Afonso and P. M. P. Gois, Eur. J. Org. Chem., 2009, 12, 1859–1863 CrossRef;
(g) N. Ma, B. Jiang, G. Zhang, S.-J. Tu, W. Wever and G.-G. Li, Green Chem., 2010, 12, 1357–1361 RSC;
(h) C. Cheng, B. Jiang, S.-J. Tu and G.-G. Li, Green Chem., 2011, 13, 2107–2115 RSC.
-
(a) M. Shibasaki, Y. Ishida, G. Iwasaki and T. Iimori, J. Org. Chem., 1987, 52, 3488–3489 CrossRef CAS;
(b) B. Jiang and M. Xu, Angew. Chem., 2004, 116, 2597–2600 (Angew. Chem., Int. Ed., 2004, 43, 2543–2546) CrossRef;
(c) Q. Xu and E. Rozners, Org. Lett., 2005, 7, 2821–2824 CrossRef CAS PubMed.
-
(a) F. Xiao, Y. Chen, Y. Liu and J. Wang, Tetrahedron, 2008, 64, 2755–2761 CrossRef CAS PubMed;
(b) D. Shibata, E. Okada, J. Molette and M. Médebielle, Tetrahedron Lett., 2008, 49, 7161–7164 CrossRef CAS PubMed;
(c) Y. Yamamoto, H. Hayashi, T. Saigoku and H. Nishiyama, J. Am. Chem. Soc., 2005, 127, 10804–10805 CrossRef CAS PubMed;
(d) D. F. Harvey and D. M. Sigano, J. Org. Chem., 1996, 61, 2268–2272 CrossRef CAS;
(e) B. Yan and Y. Liu, Org. Lett., 2007, 9, 4323–4326 CrossRef CAS PubMed;
(f) E.-S. Lee, H.-S. Yeom, J.-H. Hwang and S. Shin, Eur. J. Org. Chem., 2007, 21, 3503–3507 CrossRef.
- For some recent examples, see:
(a) C. Jiang, M. Xu, S. Wang, H. Wang and Z.-J. Yao, J. Org. Chem., 2010, 75, 4323–4325 CrossRef CAS PubMed;
(b) F. J. Fañanás, T. Arto, A. Mendoza and F. Rodríguez, Org. Lett., 2011, 13, 4184–4187 CrossRef PubMed;
(c) T. S. Symeonidis, M. G. Kallitsakis and K. E. Litinas, Tetrahedron Lett., 2011, 52, 5452–5455 CrossRef CAS PubMed.
-
(a) M. A. Huffman, N. Yasuda, A. E. DeCamp and E. J. J. Grabowski, J. Org. Chem., 1995, 60, 1590–1594 CrossRef CAS;
(b) M. Konishi, H. Ohkuma, T. Tsuno, T. Oki, G. D. VanDuyne and J. Clardy, J. Am. Chem. Soc., 1990, 112, 3715–3716 CrossRef CAS.
-
(a) M. Miura, M. Enna, K. Okuro and M. Nomura, J. Org. Chem., 1995, 60, 4999–5004 CrossRef CAS;
(b) A. Jenmalm, W. Berts, Y. L. Li, K. Luthman, I. Csoregh and U. Hacksell, J. Org. Chem., 1994, 59, 1139–1148 CrossRef CAS.
-
(a) G. Dyker, Angew. Chem., Int. Ed., 1999, 38, 1698–1712 CrossRef;
(b) T. Naota, H. Takaya and S. I. Murahashi, Chem. Rev., 1998, 98, 2599–2660 CrossRef CAS PubMed.
- For selected examples, see:
(a) C. W. Ryan and C. Ainsworth, J. Org. Chem., 1961, 26, 1547–1550 CrossRef CAS;
(b) F. Tubéry, D. S. Grierson and H.-P. Husson, Tetrahedron Lett., 1987, 28, 6457–6460 CrossRef;
(c) M. E. Jung and A. Huang, Org. Lett., 2000, 2, 2659–2661 CrossRef CAS;
(d) T. Murai, Y. Mutoh, Y. Ohta and M. Murakami, J. Am. Chem. Soc., 2004, 126, 5968–5969 CrossRef CAS PubMed.
-
(a) N. Gommermann, C. Koradin, K. Polborn and P. Knochel, Angew. Chem., 2003, 115, 5941–5944 (Angew. Chem., Int. Ed., 2003, 42, 5763–5766) CrossRef;
(b) A. Bisai and V. K. Singh, Org. Lett., 2006, 8, 2405–2408 CrossRef CAS PubMed;
(c) L. Shi, Y. Q. Tu, M. Wang, F. M. Zhang and C. A. Fan, Org. Lett., 2004, 6, 1001–1003 CrossRef CAS PubMed;
(d) N. Gommermann and P. Knochel, Chem. Commun., 2004, 2324–2325 RSC;
(e) N. Gommermann and P. Knochel, Synlett, 2005, 2799–2801 CAS;
(f) V. A. Peshkov, O. P. Pereshivko, P. A. Donets, V.
P. Mehta and E. V. Van der Eycken, Eur. J. Org. Chem., 2010, 4861–4867 CrossRef CAS;
(g) C. McDonagh, P. O'Conghaile, R. J. M. Klein Gebbink and P. O'Leary, Tetrahedron Lett., 2007, 48, 4387–4390 CrossRef CAS PubMed.
-
(a) I. Luz, F. X. Llabrés i Xamena and A. Corma, J. Catal., 2012, 285, 285–291 CrossRef CAS PubMed;
(b) C. J. Li and C. Wei, Chem. Commun., 2002, 268–269 RSC.
- C. Fischer and E. M. Carreira, Org. Lett., 2001, 3, 4319–4321 CrossRef CAS PubMed.
- C. Wei and C. J. Li, J. Am. Chem. Soc., 2003, 125, 9584–9585 CrossRef CAS PubMed.
- V. K. Y. Lo, Y. Liu, M. K. Wong and C. M. Che, Org. Lett., 2006, 8, 1529–1532 CrossRef CAS PubMed.
- C. Wei, Z. Li and C. J. Li, Org. Lett., 2003, 5, 4473–4475 CrossRef CAS PubMed.
-
(a) Y. Zhang, P. Li, M. Wang and L. Wang, J. Org. Chem., 2009, 74, 4364–4367 CrossRef CAS PubMed;
(b) J. S. Yadav, B. V. Subba Reddy, A. V. Hara Gopal and K. S. Patil, Tetrahedron Lett., 2009, 50, 3493–3496 CrossRef CAS PubMed.
- S. Samai, G. C. Nandi and M. S. Singh, Tetrahedron Lett., 2010, 51, 5555–5558 CrossRef CAS PubMed.
- P. Li, Y. Zhang and L. Wan, Chem.–Eur. J., 2009, 15, 2045–2049 CrossRef CAS PubMed.
-
(a) Z. Li, C. Wei, L. Chen, R. S. Varmab and C. J. Li, Tetrahedron Lett., 2004, 45, 2443–2446 CrossRef CAS PubMed;
(b) S. B. Park and H. Alper, Chem. Commun., 2005, 1315–1317 RSC.
- M. L. Kantam, V. Balasubrahmanyam, K. B. Shiva Kumar and G. T. Venkanna, Tetrahedron Lett., 2007, 48, 7332–7334 CrossRef CAS PubMed.
-
(a) X. Zhang and A. Corma, Angew. Chem., 2008, 120, 4430–4433 (Angew. Chem., Int. Ed., 2008, 47, 4358–4361) CrossRef;
(b) R. Maggi, A. Bello, C. Oro, G. Sartori and L. Soldi, Tetrahedron, 2008, 64, 1435–1439 CrossRef CAS PubMed;
(c) K. M. Reddy, N. S. Babu, I. Suryanarayana, P. S. Sai Prasad and N. Lingaiah, Tetrahedron Lett., 2006, 47, 7563–7566 CrossRef CAS PubMed;
(d) S. Wang, X. He, L. Song and Z. Wang, Synlett, 2009, 447–450 CAS;
(e) P. Li and L. Wang, Tetrahedron Lett., 2007, 63, 5455–5459 CrossRef CAS PubMed;
(f) B. M. Choudary, C. Sridhar, M. L. Kantam and B. Sreedhar, Tetrahedron Lett., 2004, 45, 7319–7329 CrossRef CAS PubMed;
(g) M. Wang, P. Li and L. Wang, Eur. J. Org. Chem., 2008, 13, 2255–2261 CrossRef.
- B. Sreedhar, A. Suresh Kumar and P. S. Reddy, Tetrahedron Lett., 2010, 51, 1891–1895 CrossRef CAS PubMed.
- M. Rahman, A. K. Bagdi, A. Majee and A. Hajra, Tetrahedron Lett., 2011, 52, 4437–4439 CrossRef CAS PubMed.
-
(a) Z. Li, C. Wei, L. Chen, R. S. Varma and C. J. Li, Tetrahedron Lett., 2004, 45, 2443–2446 CrossRef CAS PubMed;
(b) M. L. Kantam, B. V. Prakash, C. R. V. Reddy and B. Sreedhar, Synlett, 2005, 2329–2332 CrossRef CAS PubMed;
(c) X. Zhang and A. Corma, Angew. Chem., Int. Ed., 2008, 47, 4358–4361 CrossRef CAS PubMed;
(d) P. Li and L. Wang, Tetrahedron, 2007, 63, 5455–5459 CrossRef CAS PubMed.
-
(a) R. Huisgen, in 1,3-Dipolar Cycloaddition Chemistry, ed. A. Pawda), Wiley, New York, 1984, pp. 1–176 Search PubMed;
(b) R. Huisgen, Proc. Chem. Soc., London, 1961, 357–396 Search PubMed;
(c) R. Huisgen, Pure Appl. Chem., 1989, 61, 613–628 CrossRef CAS;
(d) H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem., Int. Ed., 2001, 40, 2004–2021 CrossRef CAS;
(e) V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596–2599 CrossRef CAS;
(f) P. Wu and V. V. Fokin, Aldrichimica Acta, 2007, 40, 7–17 CAS;
(g) A. E. Cohrt, J. F. Jensen and T. E. Nielsen, Org. Lett., 2011, 12, 5414–5417 CrossRef PubMed.
-
(a) A. Maliakal, G. Lem, N. J. Turro, R. Ravichandran, J. C. Suhadolnik, A. D. DeBellis, M. G. Wood and J. Lau, J. Phys. Chem. A, 2002, 106, 7680–7689 CrossRef CAS;
(b) H. C. Kolb and K. B. Sharpless, Drug Discovery Today, 2003, 8, 1128–1137 CrossRef CAS;
(c) P. Wu, A. K. Feldman, A. K. Nugent, C. J. Hawker, A. Scheel, B. Voit, J. Pyun, J. M. J. Frechet, K. B. Sharpless and V. V. Fokin, Angew. Chem., Int. Ed., 2004, 43, 3928–3932 CrossRef CAS PubMed;
(d) N. J. Agard, J. A. Prescher and C. R. Bertozzi, J. Am. Chem. Soc., 2004, 126, 15046–15047 CrossRef CAS PubMed;
(e) S. Wacharasindhu, S. Bardhan, Z.-K. Wan, K. Tabei and T. S. Mansour, J. Am. Chem. Soc., 2009, 131, 4174–4175 CrossRef CAS PubMed.
- M. J. Genin, D. A. Allwine, D. J. Anderson, M. R. Barbachyn, D. E. Emmert, S. E. Garmon, D. R. Graber, K. C. Grega, J. B. Hester, D. K. Hutchinson, J. Morris, R. J. Reischer, C. W. Ford, G. E. Zurenko, J. C. Hamel, R. D. Schaadt, D. Stapert and B. H. Yagi, J. Med. Chem., 2000, 43, 953–970 CrossRef CAS PubMed.
- R. Alvarez, S. Velazquez, A. San-Felix, S. Aquaro, E. De Clercq, C.-F. Perno, A. Karlsson, J. Balzarini and M. J. Camarasa, J. Med. Chem., 1994, 37, 4185–4194 CrossRef CAS.
- D. R. Buckle, C. J. M. Rockell, H. Smith and B. A. Spicer, J. Med. Chem., 1986, 29, 2262–2267 CrossRef CAS.
- M. Tanaka, T. Yamazaki and M. Kajitani, Eur. Pat., 158494, 1985Chem. Abstr. 1986, 104, 186239.
-
(a) R. K. Smalley and M. Teguiche, Synthesis, 1990, 654–656 CrossRef CAS;
(b) L. Bertelli, G. Biagi, I. Giorgi, O. Livi, C. Manera, V. Scartoni, C. Martini, G. Giannaccini, L. Trincavelli and P. L. Barili, Farmaco, 1998, 53, 305–311 CrossRef CAS.
-
(a) W. Q. Fan and A. R. Katritzky, in: Comprehensive Heterocyclic Chemistry, ed. A. R. Katritzky, C. W. Rees and E. F. V. Scriyen, Elsevier Science, Oxford, 1996, vol. 4, pp. 1–126 Search PubMed;
(b) B. S. Holla, M. Mahalinga, M. S. Karthikeyan, B. Poojary, P. M. Akberali and N. S. Kumari, Eur. J. Med. Chem., 2005, 1173–1178 CrossRef CAS PubMed;
(c) M. A. Elmorsi and A. M. Hassanein, Corros. Sci., 1999, 41, 2337–2352 CrossRef CAS;
(d) D. K. Kim, J. Kim and H. Park, Bioorg. Med. Chem. Lett., 2004, 14, 2401–2405 CAS.
-
(a) R. D. Norcross and I. Paterson, Chem. Rev., 1995, 95, 2041–2114 CrossRef CAS;
(b) D. J. Faulkner, Nat. Prod. Rep., 2002, 19, 1–48 CAS;
(c) D. Askin, K. K. Eng, K. Rossen, R. M. Purick, K. M. Wells, R. P. Volante and P. J. Reider, Tetrahedron Lett., 1994, 35, 673–676 CrossRef CAS;
(d) K. Rossen, S. A. Weissman, J. Sagar, A. Reamer, D. A. Askin, R. P. Volante and P. J. Reider, Tetrahedron Lett., 1995, 36, 6419–6422 CrossRef CAS;
(e) B. D. Dorsey, R. B. Levin, S. L. McDaniel, J. P. Vacca, J. P. Guare, P. L. Darke, J. A. Zugay, E. A. Emini, W. A. Schleif, J. C. Quintero, J. H. Lin, I. W. Chen, M. K. Holloway, P. M. D. Fitzgerald, M. G. Axel, D. Ostovic, P. S. Anderson and J. R. Huff, J. Med. Chem., 1994, 37, 3443–3451 CrossRef CAS;
(f) P. Choudhary, R. Kumar and K. Verma, Bioorg. Med. Chem., 2006, 14, 1819–1826 CrossRef PubMed;
(g) R. S. Upadhayaya, N. Sinha, S. Jain, N. Kishore, R. Chandra and S. K. Arora, Bioorg. Med. Chem., 2004, 12, 2225–2238 CrossRef CAS PubMed;
(h) M. Kimura, T. Masuda, K. Yamada, N. Kobuta, N. Kawakatsu, M. Mitani, K. Kishi, M. Inazu and T. Namiki, Bioorg. Med. Chem. Lett., 2002, 12, 1947–1950 CrossRef CAS;
(i) A. Ryckebusch, R. Poulain, L. Maes, M. A. Debreu-Fontaine, E. Mouray, P. Grellier and C. Sergheraert, J. Med. Chem., 2003, 46, 542–557 CrossRef CAS PubMed;
(j) J. P. Yevich, J. S. New, D. W. Smith, W. G. Lobeck, J. D. Catt, J. L. Minielli, M. S. Eison, D. P. Taylor, L. A. Riblet and D. L. Temple, J. Med. Chem., 1986, 29, 359–369 CrossRef CAS.
- A. P. Dhondge, S. N. Afraj, C. Nuzlia, C. Chen and G.-H. Lee, Eur. J. Org. Chem., 2013, 19, 4119–4130 CrossRef.
- For Mn-catalyzed reactions of activated aryl halides with RMgX:
(a) G. Cahiez, F. Lepifre and P. Ramiandrasoa, Synthesis, 1999, 2138–2144 CrossRef CAS PubMed;
(b) G. Cahiez, D. Luart and F. Lecomte, Org. Lett., 2004, 6, 4395–4398 CrossRef CAS PubMed;
(c) M. Rueping and W. Ieawsuwan, Synlett, 2007, 247–250 CrossRef CAS PubMed ; For a Mn-catalyzed reaction of RMgX with 1-chloro-1,3-dienes and 1-chloro-1,3-enynes:;
(d) M. Alami, P. Ramiandrasoa and G. Cahiez, Synlett, 1998, 325–327 CAS;
(e) For a Mn-catalyze reaction with aryl or alkynyltin: S.-K. Kang, J.-S. Kim and S.-C. Choi, J. Org. Chem., 1997, 62, 4208–4209 CrossRef CAS ; For a Mn-catalyzed reaction with organoalanes: ;
(f) K. Fugami, K. Oshima and K. Utimoto, Chem. Lett., 1987, 16, 2203–2206 CrossRef ; For various Mn-catalyzed homocoupling reactions:;
(g) G. Cahiez, D. Bernard and J. F. Normant, J. Organomet. Chem., 1976, 113, 99–106 CrossRef CAS;
(h) S.-K. Kang, T.-G. Baik, X. H. Jiao and Y.-T. Lee, Tetrahedron Lett., 1999, 40, 2383–2384 CrossRef CAS.
- D. Nils, B. Anders and A. Hans, Adv. Synth. Catal., 2004, 346, 1101–1105 CrossRef.
-
(a) S. J. Benkovic, P. A. Benkovic and D. R. Comfort, J. Am. Chem. Soc., 1969, 91, 1860–1861 CrossRef CAS;
(b) N. J. Leonad and J. V. Pauketelis, J. Org. Chem., 1963, 28, 3021–3024 CrossRef.
-
(a) R. Brawn, M. Welzel, J. Lowe and J. Panek, Org. Lett., 2010, 12, 336–339 CrossRef CAS PubMed;
(b) V. Fiandanese, I. Marino and A. Punzi, Tetrahedron, 2012, 68, 10310–10317 CrossRef CAS PubMed.
Footnote |
† Electronic supplementary information (ESI) available. CCDC 956372. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c4ra03232b |
|
This journal is © The Royal Society of Chemistry 2014 |
Click here to see how this site uses Cookies. View our privacy policy here.